Source: Health Canada shortage reports · Updated Aug 17, 2026
Some Nystatin products are in shortage in Canada (2 of 8 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Mar 26, 2027.
An antifungal used to treat yeast infections of the mouth, skin and digestive tract.
Products affected
2 / 8
In shortage since
Jun 3, 2026
Est. full return
Mar 26, 2027
Reports on file
60
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · since Aug 1, 2026, est. end Mar 26, 2027 · Shortage of an inactive ingredient or component.
Active shortage
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · since Jun 24, 2026, est. end Mar 26, 2027 · Shortage of an inactive ingredient or component.
Active shortage
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · since Jun 3, 2026, no end estimate · Disruption of the manufacture of the drug.
Resolved
JAMP-NYSTATIN ORAL SUSPENSION USP
100000UNIT · SUSPENSION · JAMP PHARMA CORPORATION
DIN 02433443 · ended Aug 18, 2025 · Demand increase for the drug.
Resolved
JAMP-NYSTATIN ORAL SUSPENSION USP
100000UNIT · SUSPENSION · JAMP PHARMA CORPORATION
DIN 02433443 · ended Jul 14, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Mar 26, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
Resolved
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · ended Oct 30, 2024 · Disruption of the manufacture of the drug.
Resolved
NYADERM
100000UNIT · CREAM · TARO PHARMACEUTICALS INC
DIN 00716871 · ended Oct 29, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Oct 10, 2024 · Disruption of the manufacture of the drug.
Discontinued
NYADERM
25000UNIT · CREAM · TAROPHARMA, A DIVISION OF TARO PHARMACEUTICALS INC.
DIN 00716901
Resolved
TEVA-NYSTATIN
100000UNIT · SUSPENSION · TEVA CANADA LIMITED
DIN 02194201 · ended Jun 18, 2024 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Nystatin is currently affected by 2 active shortage reports filed with Health Canada by TARO PHARMACEUTICALS INC, TEVA CANADA LIMITED.
The reported causes are: shortage of an inactive ingredient or component; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Nystatin is classified under “INTESTINALANTIINFECTIVES” (ATC A07AA).
Recent changes
Aug 17, 2026
New report filed
Aug 17, 2026
New report filed
Common questions
What is Nystatin used for?
An antifungal used to treat yeast infections of the mouth, skin and digestive tract.
When will Nystatin be back in stock in Canada?
The latest manufacturer estimate is Mar 26, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Nystatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.